As CaM/Ca2+ and PP2A binds to the same CBD region of PRG-1 C-terminal, the increase of intracellular Ca2+ changes PRG-1 function by inhibiting PRG-1/PP2A binding, leads to dendrite spine density decrease and bone cancer pain. The gene discussed is PLPPR4; the disease is bone neoplasm.